This includes the type of address, DNS content, ISP and location details.
At the bottom of the page you can find more functions like a detailed map, whois information and an e-mail blacklist check.
This embodiment therefore is useful for conjugating the peptide to PEG molecules that will slow the clearance of the peptide from the patient's bloodstream, to peptides that will target both peptides to a specific tissue or cell, or to another peptide of complementary therapeutic use.
Therefore, in one exemplary embodiment, the N-linked glycans of peptides expressed in CHO cells are remodeled to the preferred humanized glycan by contacting the peptides with a glycosyltransferase that is specific for a galactose acceptor molecule and a sialic acid donor molecule. In another exemplary embodiment, the N-linked glycans of a peptide expressed and secreted from CHO cells are remodeled to be the preferred PEGylated structures.
This embodiment is particularly advantageous for recombinant antibody molecules expressed in heterologous cellular systems.
Below you will find the lookup results for public IP address 2.181.
HDL-related molecules, including Apo A-I, bovine HDL and HDL mimetics, in particular, are demonstrated to prevent UV-induced cell death and oxidative stress in skin cells and to inhibit tumor growth and development in a variety of cancers. The method comprises contacting the epithelial cells with an HDL-related molecule selected from the group consisting of HDL mimetic peptides (such as those shown in SEQ ID NO: 1, 3-9, 12, 14 or 26-28), bovine HDL, and Apo A-I.
Click on that and under Build you will find Publish Website.
Change your email preferences To manage your email preferences, visit the Local Guides settings page.
You can unsubscribe from one or all email types (e.g., the newsletter) without affecting others (e.g., benefits).
The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group a peptide.
This embodiment is particularly advantageous for human peptides expressed in heterologous cellular expression systems.
Specifies the resource that the contained configuration settings apply to.